272 related articles for article (PubMed ID: 11500381)
1. PML RING suppresses oncogenic transformation by reducing the affinity of eIF4E for mRNA.
Cohen N; Sharma M; Kentsis A; Perez JM; Strudwick S; Borden KL
EMBO J; 2001 Aug; 20(16):4547-59. PubMed ID: 11500381
[TBL] [Abstract][Full Text] [Related]
2. The RING domains of the promyelocytic leukemia protein PML and the arenaviral protein Z repress translation by directly inhibiting translation initiation factor eIF4E.
Kentsis A; Dwyer EC; Perez JM; Sharma M; Chen A; Pan ZQ; Borden KL
J Mol Biol; 2001 Sep; 312(4):609-23. PubMed ID: 11575918
[TBL] [Abstract][Full Text] [Related]
3. Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.
Topisirovic I; Capili AD; Borden KL
Mol Cell Biol; 2002 Sep; 22(17):6183-98. PubMed ID: 12167712
[TBL] [Abstract][Full Text] [Related]
4. The promyelocytic leukemia (PML) protein suppresses cyclin D1 protein production by altering the nuclear cytoplasmic distribution of cyclin D1 mRNA.
Lai HK; Borden KL
Oncogene; 2000 Mar; 19(13):1623-34. PubMed ID: 10763819
[TBL] [Abstract][Full Text] [Related]
5. The emerging roles of translation factor eIF4E in the nucleus.
Strudwick S; Borden KL
Differentiation; 2002 Mar; 70(1):10-22. PubMed ID: 11963652
[TBL] [Abstract][Full Text] [Related]
6. eIF4E is a central node of an RNA regulon that governs cellular proliferation.
Culjkovic B; Topisirovic I; Skrabanek L; Ruiz-Gutierrez M; Borden KL
J Cell Biol; 2006 Nov; 175(3):415-26. PubMed ID: 17074885
[TBL] [Abstract][Full Text] [Related]
7. The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.
Topisirovic I; Culjkovic B; Cohen N; Perez JM; Skrabanek L; Borden KL
EMBO J; 2003 Feb; 22(3):689-703. PubMed ID: 12554669
[TBL] [Abstract][Full Text] [Related]
8. Mutations in the S4-H2 loop of eIF4E which increase the affinity for m7GTP.
Spivak-Kroizman T; Friedland DE; De Staercke C; Gernert KM; Goss DJ; Hagedorn CH
FEBS Lett; 2002 Apr; 516(1-3):9-14. PubMed ID: 11959093
[TBL] [Abstract][Full Text] [Related]
9. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap.
Kentsis A; Topisirovic I; Culjkovic B; Shao L; Borden KL
Proc Natl Acad Sci U S A; 2004 Dec; 101(52):18105-10. PubMed ID: 15601771
[TBL] [Abstract][Full Text] [Related]
10. The exon junction complex is detected on CBP80-bound but not eIF4E-bound mRNA in mammalian cells: dynamics of mRNP remodeling.
Lejeune F; Ishigaki Y; Li X; Maquat LE
EMBO J; 2002 Jul; 21(13):3536-45. PubMed ID: 12093754
[TBL] [Abstract][Full Text] [Related]
11. Biophysical studies of eIF4E cap-binding protein: recognition of mRNA 5' cap structure and synthetic fragments of eIF4G and 4E-BP1 proteins.
Niedzwiecka A; Marcotrigiano J; Stepinski J; Jankowska-Anyszka M; Wyslouch-Cieszynska A; Dadlez M; Gingras AC; Mak P; Darzynkiewicz E; Sonenberg N; Burley SK; Stolarski R
J Mol Biol; 2002 Jun; 319(3):615-35. PubMed ID: 12054859
[TBL] [Abstract][Full Text] [Related]
12. Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state.
Ptushkina M; von der Haar T; Karim MM; Hughes JM; McCarthy JE
EMBO J; 1999 Jul; 18(14):4068-75. PubMed ID: 10406811
[TBL] [Abstract][Full Text] [Related]
13. CK2 and PML: regulating the regulator.
Lallemand-Breitenbach V; de Thé H
Cell; 2006 Jul; 126(2):244-5. PubMed ID: 16873055
[TBL] [Abstract][Full Text] [Related]
14. A novel shuttling protein, 4E-T, mediates the nuclear import of the mRNA 5' cap-binding protein, eIF4E.
Dostie J; Ferraiuolo M; Pause A; Adam SA; Sonenberg N
EMBO J; 2000 Jun; 19(12):3142-56. PubMed ID: 10856257
[TBL] [Abstract][Full Text] [Related]
15. Aberrant eukaryotic translation initiation factor 4E-dependent mRNA transport impedes hematopoietic differentiation and contributes to leukemogenesis.
Topisirovic I; Guzman ML; McConnell MJ; Licht JD; Culjkovic B; Neering SJ; Jordan CT; Borden KL
Mol Cell Biol; 2003 Dec; 23(24):8992-9002. PubMed ID: 14645512
[TBL] [Abstract][Full Text] [Related]
16. PML-associated repressor of transcription (PAROT), a novel KRAB-zinc finger repressor, is regulated through association with PML nuclear bodies.
Fleischer S; Wiemann S; Will H; Hofmann TG
Exp Cell Res; 2006 Apr; 312(6):901-12. PubMed ID: 16412420
[TBL] [Abstract][Full Text] [Related]
17. cAMP signalling is decisive for recovery of nuclear bodies (PODs) during maturation of RA-resistant t(15;17) promyelocytic leukemia NB4 cells expressing PML-RAR alpha.
Duprez E; Lillehaug JR; Naoe T; Lanotte M
Oncogene; 1996 Jun; 12(11):2451-9. PubMed ID: 8649787
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.
Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405
[TBL] [Abstract][Full Text] [Related]
19. Control of biochemical reactions through supramolecular RING domain self-assembly.
Kentsis A; Gordon RE; Borden KL
Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15404-9. PubMed ID: 12438698
[TBL] [Abstract][Full Text] [Related]
20. Promyelocytic leukemia protein-induced growth suppression and cell death in liver cancer cells.
Son SH; Yu E; Choi EK; Lee H; Choi J
Cancer Gene Ther; 2005 Jan; 12(1):1-11. PubMed ID: 15529177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
